Rockwell Med Statistics
Want to see RMTI full AI Analyst Report?
Rockwell Med (RMTI) Stock Statistics & Valuation Metrics
Total Valuation
Rockwell Med has a market cap or net worth of $26.64M. The enterprise value is $24.91M.
- Market Cap
- $26.64M
- Enterprise Value
- $24.91M
Share Statistics
Rockwell Med has 4,030,465 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 4,030,465
- Owned by Insiders
- 6.97%
- Owned by Institutions
- 4.52%
Financial Efficiency
Rockwell Med’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -9.49%.
- Return on Equity (ROE)
- -0.14
- Return on Assets (ROA)
- -0.09
- Return on Invested Capital (ROIC)
- -9.49%
- Return on Capital Employed (ROCE)
- -0.10
- Revenue Per Employee
- 441.13K
- Profits Per Employee
- -33.85K
- Employee Count
- 157
- Asset Turnover
- 1.21
- Inventory Turnover
- 16.81
Valuation Ratios
The current PE Ratio of Rockwell Med is -4.50. Rockwell Med’s PEG ratio is 0.60.
- PE Ratio
- -4.50
- PS Ratio
- 0.37
- PB Ratio
- 0.80
- Price to FCF
- 10.36
- Price to Operating Cash Flow
- 9.89
- PEG Ratio
- 0.60
Income Statement
In the last 12 months, Rockwell Med had revenue of 69.26M and earned -5.31M in profits. Earnings per share was -1.50.
- Revenue
- 69.26M
- Gross Profit
- 11.70M
- Operating Income
- -4.69M
- Pretax Income
- -5.31M
- Net Income
- -5.31M
- EBITDA
- -2.00M
- Earnings Per Share (EPS)
- -1.50
Cash Flow
In the last 12 months, operating cash flow was 2.68M and capital expenditures -86,000, giving a free cash flow of 2.59M billion.
- Operating Cash Flow
- 2.68M
- Free Cash Flow
- 2.59M
- Free Cash Flow per Share
- 0.65
Dividends & Yields
Rockwell Med pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 9.73%
- Earnings Yield
- -21.54%
Stock Price Statistics
- Beta
- 0.84
- 52-Week Price Change
- -23.64%
- 50-Day Moving Average
- 7.80
- 200-Day Moving Average
- 7.97
- Relative Strength Index (RSI)
- 38.37
- Average Volume (3m)
- 25.22K
Important Dates
Rockwell Med upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 12, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- ―
Financial Position
Rockwell Med as a current ratio of 3.98, with Debt / Equity ratio of 33.73%
- Current Ratio
- 3.98
- Quick Ratio
- 3.63
- Debt to Market Cap
- 0.30
- Net Debt to EBITDA
- -0.88
- Interest Coverage Ratio
- -4.17
Taxes
In the past 12 months, Rockwell Med has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Rockwell Med EV to EBITDA ratio is -12.18, with an EV/FCF ratio of 11.40.
- EV to Sales
- 0.41
- EV to EBITDA
- -12.18
- EV to Free Cash Flow
- 11.40
- EV to Operating Cash Flow
- 11.03
Balance Sheet
Rockwell Med has $22.54M in cash and marketable securities with $13.53M in debt, giving a net cash position of $9.01M billion.
- Cash & Marketable Securities
- $22.54M
- Total Debt
- $13.53M
- Net Cash
- $9.01M
- Net Cash Per Share
- $2.23
- Tangible Book Value Per Share
- $5.78
Margins
Gross margin is 18.09%, with operating margin of -7.11%, and net profit margin of -7.79%.
- Gross Margin
- 18.09%
- Operating Margin
- -7.11%
- Pretax Margin
- -7.79%
- Net Profit Margin
- -7.79%
- EBITDA Margin
- -3.34%
- EBIT Margin
- -6.23%
Analyst Forecast
The average price target for Rockwell Med is $20.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $20.00
- Price Target Upside
- 202.57% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- -3.96%
- EPS Growth Forecast
- 7.97%
Scores
- Smart Score
- ―
- AI Score
- 51

